You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics
- 2. Application of radiomics-based prediction model to predict preoperative lymph node metastasis in prostate cancer: a systematic review and meta-analysis
- 3. Sentinel lymph node biopsy omission in early-stage breast cancer: current evidence and clinical practice
- 4. Multiple drug resistance caused by germline mutation of exon 27 of BRCA2 gene in triple-negative breast cancer: a case report and literature review
- 5. Case Report: Triple-negative breast cancer with brain and meningeal metastases exhibits spatiotemporal heterogeneity in terms of HER2 expression
- 6. Radiomics models to predict axillary lymph node metastasis in breast cancer and analysis of the biological significance of radiomic features
- 7. FDA approves first twice-yearly injection that prevents HIV infection
- 8. Risk factors for adverse reactions caused by abemaciclib in breast cancer therapy
- 9. Efficacy and safety of Sacituzumab govitecan in solid tumors: a systematic review and meta-analysis
- 10. Scientists find new way to predict how bowel cancer drugs will stop working – paving the way for smarter treatments
Last updated at 10:11 GMT
Hot News Makers
Health/Pharma Companies
- 60710.42
- 54280.06
- 42459.90
- 27079.37
- 24996.34
- 22671.10
- 13177.84
- 12914.29
- 6887.42
- 6735.56
Drugs, Treatments, Trials
- 35858.55
- 11891.43
- 8793.96
- 6849.60
- 3351.72
- 1916.65
- 1203.97
- 1134.72
- 963.44
- 900.12
Last updated at 9:10 GMT
